Weekly Performance Review Jan. 18th – 22nd, 2021

The major indexes moved higher for the week, hitting new intraday highs on Thursday before a pullback on Friday. Communication services shares led the gains in the S&P 500 Index, boosted by a sharp gain in Netflix shares following its report of surprisingly large subscriber gains in the fourth quarter. Facebook and Google’s parent company, Alphabet, were also strong, as were video-gaming stocks, while energy shares lagged as oil prices fell back on a surprising rise in U.S. inventories. As fast-growing technology-related stocks led the gains, the market’s recent rotation into small-caps and value stocks reversed, at least temporarily. Trading volumes remained exceptionally high, reflecting, in part, heavy participation by individual investors.

Hopes for substantial new stimulus under the Biden administration appeared to drive much of the gains early in the week. On Tuesday, former Federal Reserve Chair and Treasury Secretary nominee Janet Yellen told the Senate Finance Committee that it was necessary to “act big” to help the economy deal with lockdowns and high unemployment. Investors may have been further encouraged by her statement that President-elect Joe Biden was focused on supporting the economy rather than raising taxes. Biden’s inauguration on Wednesday took place without any significant protests or violence, which also seemed to calm nerves on Wall Street.

Continue reading to find out how the stocks featured in this week’s WSWD trade alerts did.  



01-19-2021_BRKS up 8.9%

Brooks Automation, Inc. (BRKS) provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. Under the Brooks Semiconductor Solutions Group, products include atmospheric and vacuum robots, robotic modules, and tool automation systems that offer precision handling and clean wafer environments, among others.  Notably, the robots are well-equipped to handle wafers of all sizes, thin or bonded, and specialized wafer carriers. Further, the robots help in proactive monitoring and upgrading equipment productivity.

The company’s expected earnings growth rate for the current year is 18.6%.  If that isn’t reason enough to draw your attention to BRKS stock, consider what the experts have to say.  Of five analysts offering recommendations BRKS, 4 rate it a Strong Buy and 1 rates is a Buy.  There are no Sell or Hold ratings for the stock.

01-20-2021_CSIQ up 13.94%

Canadian Solar Inc. (CSIQ) has the potential to advance  in the upcoming months despite gaining more than 150% over the past year, based on its continued business growth, favorable earnings and revenue outlook, and favorable analyst sentiment.

Analyst sentiment, which gives a good sense of a stock’s future price movement, is good for CSIQ. It has an average broker rating of 1.64, indicating favorable analyst sentiment. Moreover, CSIQ has an impressive earnings surprise history with the company beating consensus EPS estimates in each of the trailing four quarters.

The consensus revenue estimate of $4.93 billion for 2021 represents indicates 43.6% increase year-over-year. Its EPS is expected to grow 20.4% in 2021, and at a rate of 20% per annum over the next five years.



01-21-2021_REGN down 0.5%

Regeneron Pharmaceuticals (REGN), responsible for drugs such as macular degeneration Eylea and arthritis treatment Kevzara, made headlines in 2020 for the monoclonal antibody cocktail REGN-CoV2, which was used to treat President Donald Trump’s COVID-19 infection.

In 2020 biotech stocks garnered  lots of attention.  Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that could only have been imagined in the past.

This golden age is also presenting tremendous opportunities for investors. Biotech stocks offer the potential for huge long-term returns.

While clearly REGN-CoV2 has boosted the stock, the company itself has enjoyed double-digit revenue growth on average over the past few years. And it could continue to serve investors well as one of the best biotech stocks for 2021.

01-22-2021_DRI down 1.09%

Brighter days are ahead, as restaurants will be one of the greatest beneficiaries of a successful vaccine rollout. Darden Restaurants (DRI) has already recouped its 2020 losses, and further gains could be ahead as the world starts to look a little more normal.

The company expects total sales between 65% and 70% of prior-year sales. EBITDA is anticipated in the range of $170 million to $210 million. Earnings per share from continuing operations are anticipated at 50-75 cents.

The company expects to open 35-40 net new restaurants and  project total capital spending at $250 to $300 million in fiscal 2021.

Where to invest $1,000 right now...

Before you consider buying Canadian Solar Inc., you'll want to see this.

Investing legend, Keith Kohl just revealed his #1 stock for 2022...

And it's not Canadian Solar Inc..

Jeff Bezos, Peter Thiel, and the Rockefellers are betting a colossal nine figures on this tiny company that trades publicly for $5.

Keith say’s he thinks investors will be able to turn a small $50 stake into $150,000.

Find that to be extraordinary?

Click here to watch his presentation, and decide for yourself...

But you have to act now, because a catalyst coming in a few weeks is set to take this company mainstream... And by then, it could be too late.

Click here to find out the name and ticker of Keith's #1 pick...